3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Terminated
2
Recruiting
2
Withdrawn
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
1277
Carcinoma, Non-Small-Cell Lung
926
Prostatic Neoplasms
729
Neoplasms
632
Multiple Myeloma
553
Lymphoma
539
Colorectal Neoplasms
529
Lung Neoplasms
515
Leukemia
497
Leukemia, Myeloid, Acute
472
Neoplasm Metastasis
470
Melanoma
425
Lymphoma, Non-Hodgkin
417
Ovarian Neoplasms
416
Leukemia, Lymphocytic, Chronic, B-Cell
386
Pancreatic Neoplasms
373
Recurrence
335
Precursor Cell Lymphoblastic Leukemia-Lymphoma
327
Head and Neck Neoplasms
306
Lymphoma, Large B-Cell, Diffuse
294
Glioblastoma
294
Myelodysplastic Syndromes
287
Brain Neoplasms
287
Lymphoma, Follicular
286
Stomach Neoplasms
280
Carcinoma, Renal Cell
268
Hodgkin Disease
261
Carcinoma, Hepatocellular
261
Rectal Neoplasms
256
Sarcoma
250
Interventions
vosaroxin
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Completed
×
Sarcoma, Myeloid
×
Clear all
NCT02658487
2025-04-15
VITAL
Vanderbilt-Ingram Cancer Center
Phase 2
Completed
42 enrolled
12 charts